Fluvoxamine has the potential to reduce the chance of progression to severe Covid-19. Here we describe the mechanisms that enable this ability.
Subscribe to:
Post Comments (Atom)
< + > Clinical Trials with Denali Rose – Life Sciences Today Podcast Episode 44
We’re excited to be back for another episode of the Life Sciences Today Podcast by Healthcare IT Today. My guest today is Denali Rose, VP a...
No comments:
Post a Comment